These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Drugs for Alzheimer's disease. Cranwell-Bruce LA Medsurg Nurs; 2010; 19(1):51-3. PubMed ID: 20336985 [No Abstract] [Full Text] [Related]
3. [New therapeutic approaches to Alzheimer's disease]. de Ladoucette O Soins Gerontol; 2006; (61):11-3. PubMed ID: 17063846 [No Abstract] [Full Text] [Related]
4. Practice guidelines for the diagnosis and treatment of Alzheimer's disease in a managed care setting: Part II--Pharmacologic therapy. Alzheimer's Disease (AD) Managed Care Advisory Council. Fillit H; Cummings J Manag Care Interface; 2000 Jan; 13(1):51-6. PubMed ID: 10747691 [TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease: will advances made in the past turn the tide? Semla TP Ann Pharmacother; 2007 Sep; 41(9):1494-6. PubMed ID: 17666576 [No Abstract] [Full Text] [Related]
7. Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: the evidence to date. Bullock R Alzheimer Dis Assoc Disord; 2006; 20(1):23-9. PubMed ID: 16493232 [TBL] [Abstract][Full Text] [Related]
8. Discontinuing Alzheimer's disease drug therapy: why, when, and how. Crutchfield D Director; 2008; 16(1):19-21. PubMed ID: 19343870 [TBL] [Abstract][Full Text] [Related]
9. [Therapy of Alzheimer disease]. Kovács T Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816 [TBL] [Abstract][Full Text] [Related]
10. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies. Tariot PN J Clin Psychiatry; 2006; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic options in Alzheimer's disease. Moreira PI; Zhu X; Nunomura A; Smith MA; Perry G Expert Rev Neurother; 2006 Jun; 6(6):897-910. PubMed ID: 16784412 [TBL] [Abstract][Full Text] [Related]
12. Navigating patients and caregivers through the course of Alzheimer's disease. Aupperle PM J Clin Psychiatry; 2006; 67 Suppl 3():8-14; quiz 23. PubMed ID: 16649846 [TBL] [Abstract][Full Text] [Related]
13. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease. Grossberg GT; Edwards KR; Zhao Q J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811 [TBL] [Abstract][Full Text] [Related]
14. Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine. Riepe MW; Adler G; Ibach B; Weinkauf B; Tracik F; Gunay I Dement Geriatr Cogn Disord; 2007; 23(5):301-6. PubMed ID: 17356273 [TBL] [Abstract][Full Text] [Related]
15. [Efficacy of memantine in the treatment of Alzheimer's disease]. Molinuevo Guix JL; Lladó Plarrumaní A Neurologia; 2005 Dec; 20(10):686-91. PubMed ID: 16317590 [TBL] [Abstract][Full Text] [Related]
16. Combination drug therapy for Alzheimer's disease: what is evidence-based, and what is not? Xiong G; Doraiswamy PM Geriatrics; 2005 Jun; 60(6):22-6. PubMed ID: 15948662 [TBL] [Abstract][Full Text] [Related]
17. [Drug therapy for Alzheimer's disease]. Shoji M Brain Nerve; 2010 Jul; 62(7):777-85. PubMed ID: 20675882 [TBL] [Abstract][Full Text] [Related]
18. [Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands]. Schölzel-Dorenbos CJ; Tijdschr Gerontol Geriatr; 2005 Jul; 36(3):122-6. PubMed ID: 16078659 [TBL] [Abstract][Full Text] [Related]
19. Current approaches in the treatment of Alzheimer's disease. Shah RS; Lee HG; Xiongwei Z; Perry G; Smith MA; Castellani RJ Biomed Pharmacother; 2008; 62(4):199-207. PubMed ID: 18407457 [TBL] [Abstract][Full Text] [Related]
20. Current pharmacotherapy for Alzheimer's disease. Lleó A; Greenberg SM; Growdon JH Annu Rev Med; 2006; 57():513-33. PubMed ID: 16409164 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]